Products / Services
  • Products / Services
  • Companies
  • Buy Leads
    Post Buy Requirement

    BICALUTAMIDE TABLET 50MG, For Clinical, Hospital Etc.

    • ApplicationClinical, hospital etc.
    • CategoryAnti Cancer Tablets
    • Packaging TypePlastic Bottle
    • Dosage5mg
    • Supply TypeManufacturer, Exporter, Supplier, Retailer
    • Preferred Buyer Location All over the world
    View More Details
    Send Enquiry

    Company Information

    location Kandivali East, Mumbai, Maharashtra
    4.3/5fill iconfill iconfill iconfill iconhalf icon(30)
    View Number
    • calendar Member Since 15 Years
    • building Nature of Business Retailer
    • gst icon GST No. 27AAHPM3187H1ZG

    Ask for more detail from the seller

    Contact Supplier
    Report incorrect details
    • Product Details

    • Company Details

    no_img_icon

    • CategoryAnti Cancer Tablets
    • ApplicationClinical, hospital etc.
    • Dosage5mg
    • Packaging TypePlastic Bottle
    • StorageCool and Dry Place
    • StorageCool and Dry Place
    • FormTablets / Liquid / Capsules / Powder
    • Grade StandardMedicine Grade

    BICALUTAMIDE TABLET 50MG

     

    •  androgen receptor inhibitor

    Bicalutamide Tablets, USP 50 mg are an androgen receptor inhibitor indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D2 metastatic carcinoma of the prostate.Treatment with bicalutamide should be started at least 3 days before commencing treatment with an LHRH analogue, or at the same time as surgical castration.

    India has many manufacturers locally who manufacture Bicalutamide tablets. To know more, contact us.

     

    ADDITIONAL INFORMATION

    The recommended dose for Bicalutamide Tablets, USP therapy in combination with an LHRH analog is one 50 mg tablet once daily (morning or evening).The tablets should be swallowed whole with liquid.

     

    SIDE EFFECTS-

    Body as a Whole: neoplasm; neck pain; fever; chills; sepsis; hernia; cyst

    Cardiovascular: angina pectoris; congestive heart failure; myocardial infarct; heart arrest; coronary artery disorder; syncope

    Digestive: melena; rectal hemorrhage; dry mouth; dysphagia; gastrointestinal disorder; periodontal abscess; gastrointestinal carcinoma

    Metabolic and Nutritional: edema; BUN increased; creatinine increased; dehydration; gout; hypercholesteremia

    Musculoskeletal: myalgia; leg cramps

    Nervous: hypertonia; confusion; somnolence; libido decreased; neuropathy; nervousness

    Respiratory: lung disorder; asthma; epistaxis; sinusitis

    Skin and Appendages: dry skin; alopecia; pruritus; herpes zoster; skin carcinoma; skin disorder

    Special Senses: cataract specified

    Urogenital: dysuria; urinary urgency; hydronephrosis; urinary tract disorder

    Severe hepatic changes and hepatic failure have been observed rarely. Monitor serum transaminase levels prior to starting treatment with Bicalutamide Tablets, USP, at regular intervals for the first four months of treatment and periodically thereafter, and for symptoms or signs suggestive of hepatic dysfunction. Use Bicalutamide Tablets, USP with caution in patients with hepatic impairment.

     

     


    Interested in this product? Ask for more details & Latest Price from seller
    Send Enquiry
    Share your requirements for a quick response!
    Tell us what you need?

    Looking for BICALUTAMIDE TABLET 50MG?

    Quantity
    Seller Contact Details
    To list your productBoost Your Business Visibility WorldwideRegister Now
    To list your productBoost Your Business Visibility WorldwideRegister Now
    Waiting for permission
    To search by voice, go to your browser settings and allow access to microphone

    Allow microphone access to search with voice